TY - JOUR
T1 - Nitrous Oxide Use During Labor
T2 - Satisfaction, Adverse Effects, and Predictors of Conversion to Neuraxial Analgesia
AU - Nodine, Priscilla M.
AU - Collins, Michelle R.
AU - Wood, Cristina L.
AU - Anderson, Jessica L.
AU - Orlando, Barbara S.
AU - McNair, Bryan K.
AU - Mayer, David C.
AU - Stein, Deborah J.
N1 - Publisher Copyright:
© 2020 by the American College of Nurse-Midwives
PY - 2020/5/1
Y1 - 2020/5/1
N2 - Introduction: Women desire safe and effective choices for pain management during labor. Currently, neuraxial and opioid analgesia are the most common methods used in the United States. The purpose of this study was to investigate demographic characteristics, safety, and satisfaction in a cohort of parturients who used inhaled nitrous oxide (N2O) analgesia and to determine predictors of conversion from N2O to neuraxial analgesia. Methods: This was a prospective chart review study. Individuals aged at least 18 years who used inhaled N2O during the first or second stage of labor between March 1, 2016, and July 23, 2017, on the labor and delivery unit of one academic medical center (N = 463) and their neonates were included. Data describing maternal and neonatal factors are reported. Logistic regression and chi-square tests were used to model the effects of oxytocin augmentation, labor induction, parity, prior cesarean birth, pre-N2O cervical dilatation, and post-N2O cervical dilatation on the odds of conversion from N2O to neuraxial analgesia. Results: In this cohort, 31% who chose N2O for analgesia did not convert to any other analgesic method. Significant positive predictors for conversion from N2O to neuraxial analgesia included labor induction (odds ratio [OR], 2.9; 95% CI, 1.7-5.0), oxytocin augmentation (OR, 3.1; 95% CI, 1.6-6.0), and labor after cesarean (OR, 6.4; 95% CI, 2.5-16.5). Multiparity (OR, 0.4; 95% CI, 0.2-0.6) and post-N2O cervical dilatation (OR, 0.8; 95% CI, 0.7-0.9) were negative predictors. Adverse effects related to N2O use during labor were rare (8%) and were not a significant reason for conversion to neuraxial analgesia. Parturients had moderately high satisfaction with N2O for pain management (11-point scale, mean [SD], 7.4 [2.9]). Five-minute Apgar scores were 7 or greater in 97.8% of the newborns. Discussion: Understanding predictors of conversion from inhaled N2O to neuraxial analgesia may assist perinatal care providers in their discussions with women about analgesia options during labor. N2O is a useful, safe option for labor analgesia in the United States.
AB - Introduction: Women desire safe and effective choices for pain management during labor. Currently, neuraxial and opioid analgesia are the most common methods used in the United States. The purpose of this study was to investigate demographic characteristics, safety, and satisfaction in a cohort of parturients who used inhaled nitrous oxide (N2O) analgesia and to determine predictors of conversion from N2O to neuraxial analgesia. Methods: This was a prospective chart review study. Individuals aged at least 18 years who used inhaled N2O during the first or second stage of labor between March 1, 2016, and July 23, 2017, on the labor and delivery unit of one academic medical center (N = 463) and their neonates were included. Data describing maternal and neonatal factors are reported. Logistic regression and chi-square tests were used to model the effects of oxytocin augmentation, labor induction, parity, prior cesarean birth, pre-N2O cervical dilatation, and post-N2O cervical dilatation on the odds of conversion from N2O to neuraxial analgesia. Results: In this cohort, 31% who chose N2O for analgesia did not convert to any other analgesic method. Significant positive predictors for conversion from N2O to neuraxial analgesia included labor induction (odds ratio [OR], 2.9; 95% CI, 1.7-5.0), oxytocin augmentation (OR, 3.1; 95% CI, 1.6-6.0), and labor after cesarean (OR, 6.4; 95% CI, 2.5-16.5). Multiparity (OR, 0.4; 95% CI, 0.2-0.6) and post-N2O cervical dilatation (OR, 0.8; 95% CI, 0.7-0.9) were negative predictors. Adverse effects related to N2O use during labor were rare (8%) and were not a significant reason for conversion to neuraxial analgesia. Parturients had moderately high satisfaction with N2O for pain management (11-point scale, mean [SD], 7.4 [2.9]). Five-minute Apgar scores were 7 or greater in 97.8% of the newborns. Discussion: Understanding predictors of conversion from inhaled N2O to neuraxial analgesia may assist perinatal care providers in their discussions with women about analgesia options during labor. N2O is a useful, safe option for labor analgesia in the United States.
KW - intrapartum coping
KW - intrapartum pain
KW - neuraxial analgesia
KW - nitrous oxide
KW - obstetric analgesia
UR - http://www.scopus.com/inward/record.url?scp=85085574126&partnerID=8YFLogxK
U2 - 10.1111/jmwh.13124
DO - 10.1111/jmwh.13124
M3 - Article
C2 - 32452155
AN - SCOPUS:85085574126
SN - 1526-9523
VL - 65
SP - 335
EP - 341
JO - Journal of Midwifery and Women's Health
JF - Journal of Midwifery and Women's Health
IS - 3
ER -